A Review of Recent Advances in the Treatment of Elderly and Poor Performance NSCLC

Until recently, chemotherapy has remained the mainstay of treatment for the majority of patients with advanced non-small cell lung cancer (NSCLC). Excellent responses have been observed with immune-checkpoint inhibitors, and targeted treatments for those tumours with actionable mutations, resulting...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmichael, Juliet A., Wing-san Mak, Daisy, O’Brien, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070834/
https://www.ncbi.nlm.nih.gov/pubmed/30021993
http://dx.doi.org/10.3390/cancers10070236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070834/
https://www.ncbi.nlm.nih.gov/pubmed/30021993
http://dx.doi.org/10.3390/cancers10070236

Ejemplares similares